Total Payments
$3,032
2024 Payments
$1,747
Companies
15
Transactions
79
Medicare Patients
281
Medicare Billing
$22,314
Payment Breakdown by Category
Food & Beverage$3,032 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,032 | 79 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $843.88 | 34 | $0 (2024) |
| GlaxoSmithKline, LLC. | $387.35 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $228.53 | 5 | $0 (2024) |
| ViiV Healthcare Company | $223.08 | 9 | $0 (2024) |
| ABBVIE INC. | $202.62 | 5 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $186.09 | 5 | $0 (2024) |
| Shionogi Inc | $180.85 | 3 | $0 (2024) |
| Lilly USA, LLC | $148.91 | 2 | $0 (2023) |
| Amgen Inc. | $138.87 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,747 | 53 | Gilead Sciences, Inc. ($533.91) |
| 2023 | $932.81 | 23 | Lilly USA, LLC ($148.91) |
| 2022 | $351.94 | 3 | Gilead Sciences, Inc. ($250.00) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: Gastroenterology | ||||||
| 12/12/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: COVID-19 | ||||||
| 12/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.74 | General |
| 11/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.90 | General |
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.22 | General |
| 11/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $7.13 | General |
| 10/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $10.01 | General |
| 10/22/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: Gastroenterology | ||||||
| 10/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $8.65 | General |
| 10/10/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $7.38 | General |
| 09/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.30 | General |
| 09/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $123.74 | General |
| Category: VACCINES | ||||||
| 09/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.78 | General |
| 09/05/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: ANTIBIOTIC | ||||||
| 08/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $8.62 | General |
| 08/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: RESPIRATORY | ||||||
| 08/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $10.51 | General |
| 08/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.07 | General |
| 08/01/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: ANTIBIOTIC | ||||||
| 07/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.71 | General |
| 07/17/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/03/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/27/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: ANTIBIOTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 281 | 741 | $88,680 | $22,314 |
Total Patients
281
Total Services
741
Medicare Billing
$22,314
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 102 | $30,600 | $9,578 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 53 | $13,250 | $3,528 | 26.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 35 | 60 | $9,000 | $2,507 | 27.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 41 | 219 | $21,900 | $2,321 | 10.6% |
| J3490 | Unclassified drugs | Office | 2023 | 27 | 50 | $1,750 | $1,372 | 78.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 16 | $4,800 | $1,356 | 28.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 20 | $4,000 | $1,127 | 28.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 13 | $1,300 | $369.33 | 28.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 39 | 104 | $1,040 | $107.79 | 10.4% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 20 | 104 | $1,040 | $47.26 | 4.5% |
About Shuyan Liu, NP
Shuyan Liu, NP is a Family healthcare provider based in Glendora, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2021. The National Provider Identifier (NPI) number assigned to this provider is 1427624576.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shuyan Liu, NP has received a total of $3,032 in payments from pharmaceutical and medical device companies, with $1,747 received in 2024. These payments were reported across 79 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($3,032).
As a Medicare-enrolled provider, Liu has provided services to 281 Medicare beneficiaries, totaling 741 services with total Medicare billing of $22,314. Data is available for 1 year (2023–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Glendora, CA
- Active Since 05/30/2021
- Last Updated 10/22/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1427624576
Products in Payments
- Vemlidy (Drug) $274.97
- Epclusa (Drug) $250.00
- JARDIANCE (Drug) $250.00
- XIFAXAN (Drug) $186.09
- DOVATO (Drug) $185.49
- Fetroja (Drug) $180.85
- EVENITY (Biological) $138.87
- AREXVY (Drug) $138.43
- RECARBRIO (Drug) $125.00
- AIRSUPRA (Drug) $124.89
- CREON (Drug) $124.77
- SHINGRIX (Biological) $123.74
- DIFICID (Drug) $103.53
- XARELTO (Drug) $101.94
- AVYCAZ (Drug) $69.14
- NUZYRA (Drug) $67.56
- Kerendia (Drug) $50.98
- CABENUVA (Biological) $37.59
- MOUNJARO (Drug) $23.91
- FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) $21.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Glendora
Steve Yang, Np, NP
Family — Payments: $9,887
Family $9,887
Chelsea Fujita-Haffner, Np-C, NP-C
Family — Payments: $7,221
Family $7,221
Nancy Rehfeld
Family — Payments: $4,146
Family $4,146
Ms. Kelly Sharkey, Np-C, NP-C
Family — Payments: $2,145
Family $2,145
Jennifer Anotado, Rn Fnp, RN FNP
Family — Payments: $1,696
Family $1,696
Beth Bergman, Msn, Rn, Apn-C, MSN, RN, APN-C
Family — Payments: $737.57
Family $737.57